Nazarova, Liliia Sh.,
Danilko, Ksenia V.,
Malievsky, Viktor A.,
Karimov, Denis O.,
Bakirov, Akhat B.,
Viktorova, Tatyana V. (2022) , PTPN22 rs2476601, and PADI4 rs2240336) in the formation of a
genetic predisposition to juvenile
Kudoyarov, E.R.,
Karimov, D.O.,
Bakirov, A.B.,
Mukhammadieva, G.F.,
Karimova, L.K.,
Galimova, R.R. (2022) detect risk groups relying on, among other things, analysis of workers’
genetic peculiarities
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) 2, CHEK2 and NBN genes,
potentially pathogenic
genetic variants in new breast and ovarian cancer
KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) and
genetic changes that promote tumorigenesis, effec‑
tive treatment options are limited. The present review
Lin, Jianjun,
Lin, Ke,
Huang, Lijiang,
Jiang, Yongsheng,
Ding, Xiaoxiao,
Luo, Wu,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Liang, Guang,
Qian, Jianchang,
Wang, Yi (2022) with TLR4 and its adaptor protein myeloid differentiation protein 2 (MD2).
Genetic loss of MD2 ameliorates